This looks amazing. This is something that I would probably recommend to my clients as a consultant as a tool they could use to build their own tools. Right now I tend to recommend Airtable but that has issues and deficiencies with building tools/UIs on top of it.
I guess a lot of comments here will be about low-code which probably speaks to the bias of HN but that's kind of silly since low-code is extremely powerful and pervasive in the corporate world now.
Can you explain why the emphasis is on the collaboration on tool building? The collaboration ability seems like a cool and valuable feature but it seems really confusing to make that so central to the marketing.
The tool building itself is extremely valuable and sophisticated on its own. That must have taken an enormous amount of work so I don't understand why the collaborative aspect is the main thing being highlighted.
> Spewing hate at the system or at practitioners is just fucking awful.
It's as awful as it is unwarranted.
> The system can’t afford to throw Dr. House and his team at every patient walking in off the street.
Telling a patient they're inoperable or not a candidate for immunotherapy or are going to die in 6 months from their disease is immoral and yet very common. It's really not difficult to just say to someone "based on my experience and the protocols we have at this institution, this is what I believe to be the case for your situation but you may find others with a different perspective".
There's a seriously depraved amount of egoism and elitism in the medical world, in particular among younger medical professionals.
> They’re essentially sitting there all day making trolley-track-payoff decisions.
Yes but that's precisely not their job in a non-emergency context. They're not philosophers, they're not Maimonides. Their job is to provide medical expertise, not make value judgements on behalf of patients or arrogate themselves to a level of expertise or knowledge they don't have.
There was an enormous amount of liquidity pumped into the system by fiscal and monetary authorities. That all these companies massively increased headcount is entirely rational. Wealthy people and companies did very well during the pandemic because they were direct beneficiaries of the fiscal and monetary support.
For complementary medical diets for the treatment of cancer the idea is to reduce inflammation in the microenvironment around the tumor. Most complementary medicine anti-cancer diets promote high anti-oxidant, low inflammation foods and supplement regimens which include antioxidants such as NAC.
Patients on such regimens (which also included traditional chemotherapy) generally showed significantly improved survival rates compared to the control which just had the chemotherapy.
This is honestly one of the most impressive things I've seen. This is sci-fi levels of technology. It's very cool, inspiring, and refreshing to see such ambitious projects.
There's an asymmetry in the risks associated with choosing either a) to restrict or b) not to restrict the set of foods you eat.
Overconfidence in (b) carries more risk than overconfidence in (a). The set of chemicals that are toxic is much larger (as in >>>) than the set of chemicals that are necessary for sustaining life.
I skimmed through the presentation and I'm not sure how you arrived at that as your takeaway. The dietary advice given in there is much more complex than that.
If anyone has a Kindle and is willing to help us beta test a new RSS/newsletter reading service for the Kindle please email me at the email address in my bio. I would love to get your feedback.
It's only wise to buy stocks when the Federal Reserve is printing money or you know that they will print money.